Oncolytics Biotech (ONCY) Non-Current Assets (2009 - 2026)
Oncolytics Biotech's Non-Current Assets was $602,000 in Q2 2026, down 22.6% from $778,006 a year earlier.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Oncolytics Biotech came in at $738,000, down 23.0% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of 10.2% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $958,284 in FY2024 (+99.8%), $479,535 in FY2023 (-62.2%), $1.27 million in FY2022 (+63.0%) and $778,805 in FY2021 (+71.3%).
- The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q4 2023.
- Compared with a year earlier, Non-Current Assets was higher in two of the last seven quarters, with growth averaging 8.8%.
- The best year-over-year quarter for Non-Current Assets over five years was Q4 2024 (growth of 97.6%); the worst was Q4 2023 (a decline of 60.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Oncolytics Biotech | 47.36 Mn | 23.68 Mn | - | 602,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 602,000.00 |
| Mar 31, 2026 | 674,000.00 |
| Dec 31, 2025 | 738,000.00 |
| Sep 30, 2025 | 722,898.44 |
| Jun 30, 2025 | 787,931.07 |
| Mar 31, 2025 | 849,110.04 |
| Dec 31, 2024 | 914,298.40 |
| Sep 30, 2024 | 998,608.33 |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 489,054.82 |
| Sep 30, 2023 | 557,408.64 |
| Jun 30, 2023 | 732,830.14 |
| Mar 31, 2023 | 789,090.30 |
| Dec 31, 2022 | 1.22 Mn |
| Sep 30, 2022 | 551,176.26 |
| Jun 30, 2022 | 645,696.40 |
| Mar 31, 2022 | 729,600.32 |
| Dec 31, 2021 | 765,826.51 |
| Sep 30, 2021 | 784,142.75 |
API Access
Oncolytics Biotech Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();